Requip Tablet 0.25mg 21’s
Pack Size: 21 Tablets
Pharmaceutical form: Tablet
Brand Name: [button link=”https://www.almishkat.pk/product-category/brand-companies/glaxo-smith-kline/” color=”purple” newwindow=”yes”] GlaxoSmithKline[/button]
Availability: In stock
- Reviews (0)
Requip Tablet 0.25mg 21’s
Requip Tablet 0.25mg 21’s, Requip is used to treat symptoms of Parkinson’s disease (stiffness, tremors, muscle spasms, and poor muscle control). Ropinirole is also used to treat restless legs syndrome (RLS). Only immediate-release Requip is approved to treat either Parkinson symptoms or RLS.
Ropinirole, sold under the brand name Requip among others, is a medication used to treat Parkinson’s disease (PD) and restless legs syndrome (RLS).In PD the dose needs to be adjusted to the effect and treatment should not be suddenly stopped.It is taken by mouth
This medication is used as monotherapy or as an adjunct for the treatment of idiopathic (unknown cause) Parkinson’s disease. It can also be used to treat restless legs syndrome.
Ropinirole is prescribed for mainly Parkinson’s disease, RLS and extrapyramidal symptoms. It can also reduce the side effects caused by selective serotonin reuptake inhibitors, including Parkinsonism syndrome as well as sexual dysfunction and erectile dysfunction caused by either SSRIs or antipsychotics.
Ropinirole is available in various preparations, ranging from a 0.25 mg tablet to a 5 mg tablet. The primary reason is dose titration
Side-effects include gastrointestinal upset, nausea, drowsiness, dizziness, hallucinations, confusion, fatigue, fainting, leg edema, sudden onset of sleep, hypotension (low blood pressure), and abdominal pain.
Ropinirole can cause nausea, dizziness, hallucinations, orthostatic hypotension, and sudden sleep attacks during the daytime. Unusual side effects specific to D3 agonists such as ropinirole and pramipexole can include hypersexuality, punding and compulsive gambling, even in patients without a history of these behaviours. pathological gambling,
Ropinirole is also known to cause an effect known as “augmentation” when used to treat restless legs syndrome, where over time treatment with dopamine agonists will cause RLS symptoms to become more severe. This usually leads to constant dosage increases in an attempt to offset the symptom progression. Symptoms will return to the level of severity they were experienced at before treatment was initiated if the drug is stopped
When Not To Use
The use is contraindicated in patients with kidney and liver problems.